Stock listing
NASDAQ:ZYNE Zynerba Pharmaceuticals Inc Stock
Follow Zynerba Pharmaceuticals Inc into a list and get an email when it puts out news.
Last close · NASDAQ:ZYNE
$1.30 USD
Close on Oct 11, 2023 · No longer trades
- Lowest – highest close
- $0.30 – $36.49 USDSince Aug 5, 2015 · lowest May 19, 2023 · highest Aug 13, 2015
Delisted NASDAQ:ZYNE no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:ZYNE
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Zynerba Pharmaceuticals Inc on 6ix
- Decks
- 56 decks · latest May 15, 2023
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (May 2023) | Investor deck | 39 slides | May 15, 2023 |
| Investor Presentation (March 2023) | Investor deck | 39 slides | Mar 28, 2023 |
| Investor Presentation (January 2023) | Investor deck | 37 slides | Jan 9, 2023 |
| Investor Presentation (December 2022) | Investor deck | 36 slides | Dec 21, 2022 |
| Investor Presentation (December 2022) | Investor deck | 42 slides | Dec 5, 2022 |
| Investor Presentation (November 2022) | Investor deck | 40 slides | Nov 15, 2022 |
| Investor Presentation (September 2022) | Investor deck | 40 slides | Sep 13, 2022 |
| Investor Presentation (August 2022) | Investor deck | 39 slides | Aug 10, 2022 |
| Investor Presentation (June 2022) | Investor deck | 39 slides | Jun 22, 2022 |
| Investor Presentation (May 2022) | Investor deck | 24 slides | May 16, 2022 |
Show 50 decks
This page holds 50 of 56 decks. Open Decks
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Armando Anido Other companies: Scynexis, Inc. (Director · Since at least Jan 21, 2019); Vaxart, Inc. (Director · Sep 21, 2015 – May 18, 2017 · Past); NuPathe Inc. (Chief Executive Officer, Director · Jul 25, 2012 – Feb 21, 2014 · Past); Adolor Corp (Director · May 18, 2010 – Dec 7, 2011 · Past); Auxilium Pharmaceuticals Inc (CEO & President, Director · Apr 12, 2010 – Oct 7, 2011 · Past) | Chairman & Chief Exec. Officer, Director · Aug 4, 2015 – Oct 10, 2023 · Past |
| William J Federici Other companies: Stevanato Group S.p.A. (Director · Since at least Mar 18, 2026); NuPathe Inc. (Director · Jan 5, 2011 – Feb 21, 2014 · Past); West Pharmaceutical Services, Inc. (Sr. VP & CFO · Dec 30, 2005 – Jun 8, 2018 · Past) | Director · Aug 4, 2015 – Oct 10, 2023 · Past |
| Daniel L Kisner Other companies: Dynavax Technologies Corporation (Director · Since at least May 23, 2024); Oncternal Therapeutics Inc (Director · Jun 20, 2024 – Jun 20, 2024 · Past) | Director · Oct 10, 2023 – Oct 10, 2023 · Past |
| Pamela Stephenson Other companies: Disc Medicine, Inc. (Chief Commercial Officer · Since at least Feb 26, 2024); Albireo Pharma Inc (Chief Commercial Officer · Apr 22, 2022 – Mar 2, 2023 · Past) | Director · Jun 14, 2022 – Oct 10, 2023 · Past |
| John Butler Other companies: Akebia Therapeutics, Inc. (CEO and President, Director · Since at least Jan 31, 2023) | Director · Jun 14, 2022 – Oct 10, 2023 · Past |
| Kenneth I Moch Other companies: Gamida Cell Ltd (Director · Jan 1, 2022 – Jan 31, 2024 · Past) | Director · Aug 4, 2015 – Oct 10, 2023 · Past |
| Richard A Baron Other companies: Immunome, Inc. (Director · Oct 1, 2020 – Jun 8, 2023 · Past) | Chief Financial Officer · Aug 4, 2015 – Sep 11, 2015 · Past |
| Suzanne M Hanlon | Sec, VP & General Counsel · Aug 4, 2015 – Jan 21, 2021 · Past |
| Terri B Sebree | President · Jul 18, 2022 – Oct 10, 2023 · Past |
| Warren D Cooper | Director · Oct 10, 2023 – Oct 10, 2023 · Past |
Log in to ask 6ix AI your own questions about Zynerba Pharmaceuticals Inc.